These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 14575283)
1. Antiphospholipid antibodies in patients with lupus nephritis. Fialová L; Zima T; Tesar V; Mikulíková L; Malbohan IM; Merta M; Certíková V Ren Fail; 2003 Sep; 25(5):747-58. PubMed ID: 14575283 [TBL] [Abstract][Full Text] [Related]
2. Antibodies against phospholipids and oxidized LDL in alcoholic patients. Zima T; Fialová L; Mikulíková L; Malbohan IM; Popov P; Nespor K Physiol Res; 1998; 47(5):351-5. PubMed ID: 10052604 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus. Cabral AR; Cabiedes J; Alarcón-Segovia D Lupus; 2004; 13(3):182-7. PubMed ID: 15119547 [TBL] [Abstract][Full Text] [Related]
4. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865 [TBL] [Abstract][Full Text] [Related]
5. Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lopez LR; Salazar-Paramo M; Palafox-Sanchez C; Hurley BL; Matsuura E; Garcia-De La Torre I Lupus; 2006; 15(2):80-6. PubMed ID: 16539278 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of beta 2-glycoprotein I antibody in systemic lupus erythematosus patients with beta 2-glycoprotein I dependent antiphospholipid antibodies. Matsuda J; Saitoh N; Gotoh M; Gohchi K; Tsukamoto M Ann Rheum Dis; 1995 Jan; 54(1):73-5. PubMed ID: 7880127 [TBL] [Abstract][Full Text] [Related]
7. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Lopez LR; Simpson DF; Hurley BL; Matsuura E Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973 [TBL] [Abstract][Full Text] [Related]
17. Significance of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in lupus nephritis. Loizou S; Samarkos M; Norsworthy PJ; Cazabon JK; Walport MJ; Davies KA Rheumatology (Oxford); 2000 Sep; 39(9):962-8. PubMed ID: 10986300 [TBL] [Abstract][Full Text] [Related]
18. Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. Romero FI; Amengual O; Atsumi T; Khamashta MA; Tinahones FJ; Hughes GR Br J Rheumatol; 1998 Aug; 37(8):883-8. PubMed ID: 9734680 [TBL] [Abstract][Full Text] [Related]
19. Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus. Nowak B; Szmyrka-Kaczmarek M; Durazińska A; Płaksej R; Borysewicz K; Korman L; Wiland P Adv Clin Exp Med; 2012; 21(3):331-5. PubMed ID: 23214196 [TBL] [Abstract][Full Text] [Related]
20. Anti-oxLDL antibodies--marker for arterial thromboses in antiphospholipid syndrome? Bećarevic M; Andrejević S; Bonaci-Nikolić B; Obradović I; Miljić P; Majkić-Singh N Clin Lab; 2005; 51(5-6):279-83. PubMed ID: 15991801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]